Guardant Health
GH
#3260
Rank
HK$28.00 B
Marketcap
HK$226.62
Share price
-3.64%
Change (1 day)
29.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: HK$28.00 Billion

As of November 2024 Guardant Health has a market cap of HK$28.00 Billion. This makes Guardant Health the world's 3260th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$28.00 B9.19%
2023HK$25.64 B17.79%
2022HK$21.76 B-72.54%
2021HK$79.28 B-20.62%
2020HK$99.88 B74.78%
2019HK$57.14 B126.39%
2018HK$25.24 B

End of Day market cap according to different sources

On Nov 16th, 2024 the market cap of Guardant Health was reported to be:

HK$28.00 Billion
by Nasdaq info icon info icon
HK$28.00 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$150.11 B 436.13%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.63 B-12.04%๐Ÿ‡บ๐Ÿ‡ธ USA